Structures of AMP-activated protein kinase bound to novel pharmacological activators in phosphorylated, non-phosphorylated, and nucleotide-free states

Yan Yan, X. Edward Zhou, Scott J. Novick, Simon J. Shaw, Yingwu Li, Joseph S. Brunzelle, Yasumichi Hitoshi, Patrick R. Griffin, H. Eric Xu, Karsten Melcher*

*Corresponding author for this work

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

AMP-activated protein kinase (AMPK) is an attractive therapeutic target for managing metabolic diseases. A class of pharmacological activators, including Merck 991, binds the AMPK ADaM site, which forms the interaction surface between the kinase domain (KD) of the -subunit and the carbohydrate-binding module (CBM) of the -subunit. Here, we report the development of two new 991-derivative compounds, R734 and R739, which potently activate AMPK in a variety of cell types, including 2-specific skeletal muscle cells. Surprisingly, we found that they have only minor effects on direct kinase activity of the recombinant121 isoform yet robustly enhance protection against activation loop dephosphorylation. This mode of activation is reminiscent of that of ADP, which activates AMPK by binding to the nucleotide-binding sites in the -subunit, more than 60 Å away from the ADaM site. To understand the mechanisms of full and partial AMPK activation, we determined the crystal structures of fully active phosphorylated AMPK111 bound to AMP and R734/R739 as well as partially active nonphosphorylated AMPK bound to R734 and AMP and phosphorylated AMPK bound to R734 in the absence of added nucleotides at <3-Å resolution. These structures and associated analyses identified a novel conformational state of the AMPK autoinhibitory domain associated with partial kinase activity and provide new insights into phosphorylation-dependent activation loop stabilization in AMPK.

Original languageEnglish (US)
Pages (from-to)953-967
Number of pages15
JournalJournal of Biological Chemistry
Volume294
Issue number3
DOIs
StatePublished - Jan 1 2019

Fingerprint

AMP-Activated Protein Kinases
Nucleotides
Pharmacology
Chemical activation
Phosphotransferases
Adenosine Monophosphate
Phosphorylation
Metabolic Diseases
Protein Binding
Adenosine Diphosphate
Muscle Cells
Muscle
Protein Isoforms
Skeletal Muscle
Stabilization
Crystal structure
Binding Sites
Cells
Carbohydrates
Derivatives

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Cell Biology

Cite this

Yan, Yan ; Edward Zhou, X. ; Novick, Scott J. ; Shaw, Simon J. ; Li, Yingwu ; Brunzelle, Joseph S. ; Hitoshi, Yasumichi ; Griffin, Patrick R. ; Eric Xu, H. ; Melcher, Karsten. / Structures of AMP-activated protein kinase bound to novel pharmacological activators in phosphorylated, non-phosphorylated, and nucleotide-free states. In: Journal of Biological Chemistry. 2019 ; Vol. 294, No. 3. pp. 953-967.
@article{f6c41b0d4f234b16aa67ecfded0759ab,
title = "Structures of AMP-activated protein kinase bound to novel pharmacological activators in phosphorylated, non-phosphorylated, and nucleotide-free states",
abstract = "AMP-activated protein kinase (AMPK) is an attractive therapeutic target for managing metabolic diseases. A class of pharmacological activators, including Merck 991, binds the AMPK ADaM site, which forms the interaction surface between the kinase domain (KD) of the -subunit and the carbohydrate-binding module (CBM) of the -subunit. Here, we report the development of two new 991-derivative compounds, R734 and R739, which potently activate AMPK in a variety of cell types, including 2-specific skeletal muscle cells. Surprisingly, we found that they have only minor effects on direct kinase activity of the recombinant121 isoform yet robustly enhance protection against activation loop dephosphorylation. This mode of activation is reminiscent of that of ADP, which activates AMPK by binding to the nucleotide-binding sites in the -subunit, more than 60 {\AA} away from the ADaM site. To understand the mechanisms of full and partial AMPK activation, we determined the crystal structures of fully active phosphorylated AMPK111 bound to AMP and R734/R739 as well as partially active nonphosphorylated AMPK bound to R734 and AMP and phosphorylated AMPK bound to R734 in the absence of added nucleotides at <3-{\AA} resolution. These structures and associated analyses identified a novel conformational state of the AMPK autoinhibitory domain associated with partial kinase activity and provide new insights into phosphorylation-dependent activation loop stabilization in AMPK.",
author = "Yan Yan and {Edward Zhou}, X. and Novick, {Scott J.} and Shaw, {Simon J.} and Yingwu Li and Brunzelle, {Joseph S.} and Yasumichi Hitoshi and Griffin, {Patrick R.} and {Eric Xu}, H. and Karsten Melcher",
year = "2019",
month = "1",
day = "1",
doi = "10.1074/jbc.RA118.004883",
language = "English (US)",
volume = "294",
pages = "953--967",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "3",

}

Structures of AMP-activated protein kinase bound to novel pharmacological activators in phosphorylated, non-phosphorylated, and nucleotide-free states. / Yan, Yan; Edward Zhou, X.; Novick, Scott J.; Shaw, Simon J.; Li, Yingwu; Brunzelle, Joseph S.; Hitoshi, Yasumichi; Griffin, Patrick R.; Eric Xu, H.; Melcher, Karsten.

In: Journal of Biological Chemistry, Vol. 294, No. 3, 01.01.2019, p. 953-967.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Structures of AMP-activated protein kinase bound to novel pharmacological activators in phosphorylated, non-phosphorylated, and nucleotide-free states

AU - Yan, Yan

AU - Edward Zhou, X.

AU - Novick, Scott J.

AU - Shaw, Simon J.

AU - Li, Yingwu

AU - Brunzelle, Joseph S.

AU - Hitoshi, Yasumichi

AU - Griffin, Patrick R.

AU - Eric Xu, H.

AU - Melcher, Karsten

PY - 2019/1/1

Y1 - 2019/1/1

N2 - AMP-activated protein kinase (AMPK) is an attractive therapeutic target for managing metabolic diseases. A class of pharmacological activators, including Merck 991, binds the AMPK ADaM site, which forms the interaction surface between the kinase domain (KD) of the -subunit and the carbohydrate-binding module (CBM) of the -subunit. Here, we report the development of two new 991-derivative compounds, R734 and R739, which potently activate AMPK in a variety of cell types, including 2-specific skeletal muscle cells. Surprisingly, we found that they have only minor effects on direct kinase activity of the recombinant121 isoform yet robustly enhance protection against activation loop dephosphorylation. This mode of activation is reminiscent of that of ADP, which activates AMPK by binding to the nucleotide-binding sites in the -subunit, more than 60 Å away from the ADaM site. To understand the mechanisms of full and partial AMPK activation, we determined the crystal structures of fully active phosphorylated AMPK111 bound to AMP and R734/R739 as well as partially active nonphosphorylated AMPK bound to R734 and AMP and phosphorylated AMPK bound to R734 in the absence of added nucleotides at <3-Å resolution. These structures and associated analyses identified a novel conformational state of the AMPK autoinhibitory domain associated with partial kinase activity and provide new insights into phosphorylation-dependent activation loop stabilization in AMPK.

AB - AMP-activated protein kinase (AMPK) is an attractive therapeutic target for managing metabolic diseases. A class of pharmacological activators, including Merck 991, binds the AMPK ADaM site, which forms the interaction surface between the kinase domain (KD) of the -subunit and the carbohydrate-binding module (CBM) of the -subunit. Here, we report the development of two new 991-derivative compounds, R734 and R739, which potently activate AMPK in a variety of cell types, including 2-specific skeletal muscle cells. Surprisingly, we found that they have only minor effects on direct kinase activity of the recombinant121 isoform yet robustly enhance protection against activation loop dephosphorylation. This mode of activation is reminiscent of that of ADP, which activates AMPK by binding to the nucleotide-binding sites in the -subunit, more than 60 Å away from the ADaM site. To understand the mechanisms of full and partial AMPK activation, we determined the crystal structures of fully active phosphorylated AMPK111 bound to AMP and R734/R739 as well as partially active nonphosphorylated AMPK bound to R734 and AMP and phosphorylated AMPK bound to R734 in the absence of added nucleotides at <3-Å resolution. These structures and associated analyses identified a novel conformational state of the AMPK autoinhibitory domain associated with partial kinase activity and provide new insights into phosphorylation-dependent activation loop stabilization in AMPK.

UR - http://www.scopus.com/inward/record.url?scp=85060168126&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85060168126&partnerID=8YFLogxK

U2 - 10.1074/jbc.RA118.004883

DO - 10.1074/jbc.RA118.004883

M3 - Article

C2 - 30478170

AN - SCOPUS:85060168126

VL - 294

SP - 953

EP - 967

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 3

ER -